Publications
Verma S, Bain SC, Monk Fries T, Mazer CD, Nauck MA, Pratley RE, Rasmussen S, Saevereid HA, Zinman B, Buse JB. Duration of Diabetes and Cardiorenal Efficacy of Liraglutide and Semaglutide: A Post Hoc Analysis of the LEADER and SUSTAIN 6 Clinical Trials. Diabetes Obes Metab. 2019 Jul;21(7):1745-1751. doi: 10.1111/dom.13698. Epub 2019 Apr 2. PMID: 30851070
Leiter LA, Bain SC, Hramiak I, Jódar E, Madsbad S, Gondolf T, Hansen T, Holst I, Lingvay I. Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial. Cardiovasc Diabetol. 2019 Jun 6;18(1):73. doi: 10.1186/s12933-019-0871-8. PMID: 31167654
Morris FM, Bain SC. Clumsy hands in a woman with long-standing diabetes. Diabet Med. 2019 May 25. doi: 10.1111/dme.14041. [Epub ahead of print]. PMID: 31127641.
Stephens JW, Min T, Dunseath G, Churm R, Barry JD, Prior SL. Temporal effects of laparoscopic sleeve gastrectomy on adipokines, inflammation, and oxidative stress in patients with impaired glucose homeostasis. Surg Obes Relat Dis. 2019 Apr 17. pii: S1550-7289(19)30142-X. doi: 10.1016/j.soard.2019.04.006. [Epub ahead of print]. PMID: 31711947
Stephens JW, Min T, Dunseath G, Churm R, Barry JD, Prior SL. Temporal effects of laparoscopic sleeve gastrectomy on adipokines, inflammation, and oxidative stress in patients with impaired glucose homeostasis. Surgery for Obesity and Related Diseases. 17 April 2019. doi.org/10.1016/j.soard.2019.04.006
O'Neil LK, Bain SC. An unusual finding during retinal screening. Diabet Med. 2019 Apr 19. doi: 10.1111/dme.13971. [Epub ahead of print]. PMID: 31004377
Taylor K, Bain SC. Foot deformity in a man with Type 2 diabetes. Diabet Med. 2019 Mar 21. doi: 10.1111/dme.13950. [Epub ahead of print] No abstract available. PMID: 30897242
Owens DR, Landgraf W, Frier BM, Zhang M, Home PD, Meneghini L, Bolli GB. Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0. Diabetes Obes Metab. 2019 Feb;21(2):321-329. doi: 10.1111/dom.13607. PMID: 30520217
Parsons SN, Luzio SD, Harvey JN, Bain SC, Cheung WY, Watkins A, Owens DR. Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial. Diabet Med. 2019 Jan 17. doi: 10.1111/dme.13899. [Epub ahead of print]. PMID: 30653704. Read the lay summary here
Davies M, Bain S, Charpentier G, Flacke F, Goyeau H, Woloschak M, Hasslacher C, Vespasiani G, Edelman S. A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes. J Diabetes Sci Technol. 2019 Jan 15:1932296818821706. doi: 10.1177/1932296818821706. [Epub ahead of print]. PMID: 30646755